Trajectories of Preexposure Prophylaxis Adherence Among Commercially Insured Individuals-Reference-Cited by-同舟云学术

Trajectories of Preexposure Prophylaxis Adherence Among Commercially Insured Individuals

Published:2023-12-08 Issue: Volume: Page:
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:

Author:

Unigwe Ikenna¹,Goodin Amie¹,Lo-Ciganic Wei-Hsuan²³⁴^ORCID,Cook Robert L⁵,Park Haesuk¹^ORCID

Affiliation:

1. Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida , Gainesville, Florida , USA

2. Division of General Internal Medicine, School of Medicine, University of Pittsburgh , Pittsburgh, Pennsylvania , USA

3. Center for Pharmaceutical Policy and Prescribing, Health Policy Institute, University of Pittsburgh , Pittsburgh, Pennsylvania , USA

4. North Florida/South Georgia Veterans Health System, Geriatric Research Education and Clinical Center , Gainesville, Florida , USA

5. Department of Epidemiology, College of Public Health and Health Professions and College of Medicine, University of Florida , Gainesville, Florida , USA

Abstract

Abstract We used group-based trajectory models to identify 4 distinct trajectory patterns of adherence to preexposure prophylaxis (PrEP) among 20 696 users. Only 44.5% were consistently PrEP adherent, with younger age, being female, or having substance use disorder or depression associated with early discontinuation. Public health efforts are needed to improve PrEP adherence.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

https://academic.oup.com/cid/advance-article-pdf/doi/10.1093/cid/ciad756/55014281/ciad756.pdf

Reference16 articles.

1. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men;Grant;N Engl J Med,2010

2. Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men;Anderson;Sci Transl Med,2012

3. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women;Baeten;N Engl J Med,2012

4. Oral pre-exposure prophylaxis (PrEP) to prevent HIV: a systematic review and meta-analysis of clinical effectiveness, safety, adherence and risk compensation in all populations;Murchu E;BMJ Open,2022

5. Tenofovir-based preexposure prophylaxis for HIV infection among African women;Marrazzo;N Engl J Med,2015